FDA applicant
Crestat Diagnostics, Inc.
FDA records 29 decisions for Crestat Diagnostics, Inc. (Murrieta, CA) from 1990 to 1998: 29 510(k) clearances. Most are in product codes CFN (Method, Nephelometric, Immunoglobulins (G, A, M)) and DER (Alpha-1-Lipoprotein, Antigen, Antiserum, Control). Its devices cite 5 predicates, 0 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Crestat Diagnostics, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
No FDA decision for Crestat Diagnostics, Inc. since 2007.
Recalls per year
1in 2013
Class I Class II/III not classified
Planning a device like Crestat Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report